TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.75
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST

TPEX:4157 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
7,7178,21910,91111,50511,03916,380
Upgrade
Market Cap Growth
-24.67%-24.67%-5.16%4.22%-32.60%24.19%
Upgrade
Enterprise Value
6,7567,22210,16910,54510,03215,984
Upgrade
Last Close Price
10.7511.4515.2016.0515.4022.85
Upgrade
PE Ratio
--79.80-14.23-
Upgrade
PS Ratio
51.2054.5688.61317.568.53699.34
Upgrade
PB Ratio
7.137.599.7511.868.8137.04
Upgrade
P/TBV Ratio
7.687.689.8711.868.8137.07
Upgrade
P/FCF Ratio
-3055.51-17.84-
Upgrade
P/OCF Ratio
-1462.83-17.55-
Upgrade
EV/Sales Ratio
44.8447.9482.59291.057.75682.43
Upgrade
EV/EBITDA Ratio
---11.03-
Upgrade
EV/EBIT Ratio
---11.15-
Upgrade
EV/FCF Ratio
-38.91-2847.73-16.21-
Upgrade
Debt / Equity Ratio
0.050.050.070.040.040.04
Upgrade
Debt / EBITDA Ratio
----0.06-
Upgrade
Debt / FCF Ratio
--20.92-0.09-
Upgrade
Asset Turnover
0.130.130.110.031.330.03
Upgrade
Inventory Turnover
0.420.420.460.230.780.36
Upgrade
Quick Ratio
22.4922.4922.3817.9713.413.86
Upgrade
Current Ratio
23.5723.5723.1918.5013.714.13
Upgrade
Return on Equity (ROE)
-3.51%-3.51%13.09%-21.33%91.47%-64.39%
Upgrade
Return on Assets (ROA)
-6.35%-6.35%-9.59%-14.23%57.68%-25.57%
Upgrade
Return on Capital (ROIC)
-6.54%-6.54%-9.92%-14.99%63.65%-28.65%
Upgrade
Return on Capital Employed (ROCE)
----69.00%-
Upgrade
Earnings Yield
-0.50%-0.47%1.25%-2.06%7.03%-2.47%
Upgrade
FCF Yield
-2.25%-2.11%0.03%-0.21%5.61%-1.51%
Upgrade
Buyback Yield / Dilution
-0.03%-0.03%-0.06%0.07%-0.07%-0.01%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.